Form 4: Oklo CEO Sells Over $15M in Class A Stock
Insider Transaction Report
Oklo Inc. Co-Founder and CEO Jacob DeWitte reported the sale of 200,000 shares of Class A Common Stock for approximately $15 million, executed under a Rule 10b5-1 plan.
Summary
- Jacob DeWitte, Co-Founder, CEO, Director, and 10% Owner of Oklo Inc., reported the sale of 200,000 shares of Class A Common Stock.
- The sales occurred on February 2, 2026, and were executed pursuant to a Rule 10b5-1 plan adopted on March 31, 2025.
- A total of 100,000 shares were sold directly by Jacob DeWitte and indirectly through the Jacob DeWitte GRAT, with weighted average prices ranging from $73.8095 to $78.2003.
- An additional 100,000 shares were sold indirectly through Jacob DeWitte's spouse, Caroline Cochran, and the Caroline Cochran GRAT, with identical weighted average prices.
- The total approximate value of the shares sold across all transactions is $14,990,800.
- Following these transactions, Jacob DeWitte continues to beneficially own a significant number of shares directly and indirectly through various trusts and GRATs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sales were pre-scheduled under a 10b5-1 plan, indicating planned diversification or liquidity management rather than an immediate reaction to company performance or a change in outlook.
Negatives
- Insider selling, even when pre-planned, can sometimes be perceived negatively by the market, potentially signaling a lack of confidence, though the 10b5-1 plan mitigates this concern.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The sales reported were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025.
Industry Context
StockSavvy.ai notes that insider sales, even when conducted under a pre-arranged 10b5-1 plan, are closely monitored by investors. While a 10b5-1 plan suggests planned personal financial management rather than a reaction to new company-specific information, the market often scrutinizes such transactions for any potential signals about management's long-term confidence or valuation perspective, especially for a company in the emerging nuclear energy sector like Oklo.
Related Party Transactions
- Sales of Class A Common Stock were reported as beneficially owned indirectly by Jacob DeWitte through his spouse, Caroline Cochran, and various GRATs and family trusts associated with both individuals.
Stakeholder Impact
- Shareholders may interpret significant insider sales with caution, though the existence of a 10b5-1 plan typically alleviates concerns about immediate negative implications for the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Rule 10b5-1 plan adopted for the sale of securities. |
| 02/02/2026 | Transaction date for all reported sales of Class A Common Stock. |
| 02/04/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
Recommendation
holdThe sales by CEO Jacob DeWitte were executed under a pre-arranged 10b5-1 plan, which typically indicates planned personal financial management rather than a reaction to new company-specific information. While significant in volume, the pre-scheduled nature suggests a neutral impact on the company's fundamental outlook. Investors should monitor future filings and company performance, but this specific transaction does not warrant a change from a 'hold' position.
Keywords
Oklo Inc., OKLO, Jacob DeWitte, insider trading, Form 4, stock sale, 10b5-1 plan, Class A Common Stock, CEO, Director, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.